EPO Patents = 3

Forward Citations = 0

Loading Chart...

32 inventors (with patents filed for the assignee):

Quanhai Liu (2 out of 10 patents)

Yongzhi Shu (1 out of 4 patents)

Jun Lin (1 out of 13 patents)

4. Bin Zhou (1 out of 55 patents)

5. Meng Guo (1 out of 5 patents)

6. Meihua Xie (1 out of 3 patents)

7. Fuli Zhang (1 out of 11 patents)

8. Taizhi Wu (1 out of 2 patents)

9. Jialiang Zhong (1 out of 1 patent)

10. Yu Huang (1 out of 50 patents)

11. Zhenpeng Yu (1 out of 1 patent)

12. Gouping Wang (1 out of 1 patent)

13. Minyu Liu (1 out of 4 patents)

14. Xiaoling Huang (1 out of 3 patents)

15. Lin Xiao (1 out of 3 patents)

4 patents: Sort by Forward Citations

1. 10676442 - Salt derivative of tetrahydroisoquinoline and crystalline thereof and preparation method therefore and application thereof (2020-06-09),

2. 10428013 - Amide compound, preparation method and uses thereof (2019-10-01),

3. 10112901 - Method for preparing dabigatran etexilate intermediate, and intermediate compound (2018-10-30),

4. 9650403 - Platinum (II) compound, preparation method therefor, and pharmaceutical composition and application thereof (2017-05-16),

China State Institute of Pharmaceutical Industry is a leading pharmaceutical research and development institute in China. With a history of over 60 years, the institute focuses on drug discovery, traditional Chinese medicine research, and pharmaceutical manufacturing technology. They have a strong commitment to innovation and quality in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

4 Patents

#470 in Pudong, New Area Shanghai

#5,574 in China

Pudong, New Area Shanghai, China

China State Institute of Pharmaceutical Industry